投资工具 / 美股
Merck & Co. · MRK
数据仅供参考,不构成投资建议。
投资工具 / 美股
数据仅供参考,不构成投资建议。
| 季度 | 截止日 | 申报日 | 营收 | 营收同比 g | Δg | 推导方式 |
|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | 2026-11-04 | $18.09B | +4.7% | −0.4pp | 3M |
| 2026Q2 | 2026-06-30 | 2026-08-07 | $16.61B | +5.1% | +0.2pp | 3M |
| 2026Q1 | 2026-03-31 | 2026-05-04 | $16.29B | +4.9% | −0.1pp | 3M |
| 2025Q4 | 2025-12-31 | 2026-11-04 | $16.4B | +5.0% | +1.3pp | FY-9M |
| 2025Q3 | 2025-09-30 | 2026-11-04 | $17.28B | +3.7% | +5.6pp | 3M |
| 2025Q2 | 2025-06-30 | 2026-08-07 | $15.81B | −1.9% | −0.3pp | 3M |
| 2025Q1 | 2025-03-31 | 2026-05-04 | $15.53B | −1.6% | −8.4pp | 3M |
| 2024Q4 | 2024-12-31 | 2026-02-24 | $15.62B | +6.8% | +2.4pp | FY-9M |
口径:单季同比;Δg = 本季 g − 上季 g;按财季映射日历季度;申报日可见。† 不连续点(上年同季营收 ≤0 或 Δg 幅度超过 50pp)。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 季度 | 截止日 | 毛利 | 销货成本 | 毛利率 | 环比 | 同比 | Δ² |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | 无数据 | $4.89B | 72.9% | −59bp | −474bp | −78bp |
| 2026Q2 | 2026-06-30 | 无数据 | $4.4B | 73.5% | −71bp | −396bp | −22bp |
| 季度 | 截止日 | 合同负债 | CL g | RPO | RPO g | 账单额 | 账单额 g | RPO 覆盖 |
|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 |
| 2026Q2 | 2026-06-30 | 无数据 | 无数据 |
| 季度 | 截止日 | OCF TTM | OCF g | CapEx TTM | CapEx g | FCF TTM | CapEx 密度 | SBC/FCF | SBC/Rev |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $18.7B | +9.6% | $3.96B | −1.5% | $14.75B | 5.9% | 7.2% | 1.6% |
| 2026Q2 | 2026-06-30 | $19.97B |
| 季度 | 截止日 | 存货 | 存货 g | 营收 g | 剪刀差 | DIO | DIO 同比 |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $6.16B | −4.3% | +4.7% | −9.0pp | 115.0 | −37.6 |
| 2026Q2 | 2026-06-30 | $6.21B | −6.0% | +5.1% | −11.0pp | 128.9 |
| 交易日 | 申报日 | 申报人 | 头衔 | 代码 | 股数 | 价格 | 金额 | 10b5-1 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | 2026-11-16 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | S | 58,185 | $148.01 | $8.61M |
口径:修正广度 =(近 30 日上调 − 下调)/(上调 + 下调),样本 < 3 不出;只展示衍生指标,不展示一致预期原值。 · 数据截至 2026-11-16 · 来源:Yahoo Finance / Nasdaq
未覆盖(期权覆盖为 S&P 500 期权持仓前 100 名每日、其余每周轮换)
口径:本股的警报事件历史(含基线);事件保留 90 天。
| 2026Q1 | 2026-03-31 | 无数据 | $4.2B | 74.2% | +809bp | −374bp | +561bp |
| 2025Q4 | 2025-12-31 | 无数据 | $5.55B | 66.2% | −1153bp | −935bp | −1153bp |
| 2025Q3 | 2025-09-30 | 无数据 | $3.86B | 77.7% | +19bp | +218bp | +144bp |
| 2025Q2 | 2025-06-30 | 无数据 | $3.56B | 77.5% | −49bp | +74bp | +32bp |
| 2025Q1 | 2025-03-31 | 无数据 | $3.42B | 78.0% | +248bp | +42bp | −182bp |
| 2024Q4 | 2024-12-31 | 无数据 | $3.83B | 75.5% | −1bp | +224bp | +2bp |
口径:GM = 毛利/营收;毛利缺失时用 营收−销货成本 推导;环比/同比为基点。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 无数据 |
| 无数据 |
| 无数据 |
| 无数据 |
| 2026Q1 | 2026-03-31 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 |
| 2025Q4 | 2025-12-31 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 |
| 2025Q3 | 2025-09-30 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 |
| 2025Q2 | 2025-06-30 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 |
| 2025Q1 | 2025-03-31 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 |
| 2024Q4 | 2024-12-31 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 | 无数据 |
口径:g = 同比;账单额 = 营收 + Δ合同负债(同口径);RPO 覆盖 = RPO / TTM 营收。跨口径(总额/仅流动)不比较。 合同负债口径: — · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| +7.7% |
| $3.9B |
| +2.4% |
| $16.06B |
| 5.9% |
| 5.6% |
| 1.3% |
| 2026Q1 | 2026-03-31 | $17.89B | −14.3% | $3.78B | −1.7% | $14.12B | 5.7% | 5.7% | 1.2% |
| 2025Q4 | 2025-12-31 | $16.47B | −23.3% | $4.11B | +21.9% | $12.36B | 6.3% | 6.6% | 1.3% |
| 2025Q3 | 2025-09-30 | $17.07B | −6.6% | $4.02B | +17.3% | $13.05B | 6.3% | 6.1% | 1.2% |
| 2025Q2 | 2025-06-30 | $18.53B | +11.0% | $3.81B | +7.6% | $14.72B | 6.0% | 5.4% | 1.2% |
| 2025Q1 | 2025-03-31 | $20.88B | +41.5% | $3.84B | +3.3% | $17.04B | 6.0% | 4.6% | 1.2% |
| 2024Q4 | 2024-12-31 | $21.47B | +65.1% | $3.37B | −12.7% | $18.1B | 5.3% | 4.2% | 1.2% |
口径:TTM = 近四个离散单季之和;FCF = OCF − CapEx;CapEx 密度 = CapEx/营收 TTM;FCF≤0 时 SBC/FCF 不计算。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| −40.5 |
| 2026Q1 | 2026-03-31 | $6.48B | +4.6% | +4.9% | −0.3pp | 140.9 | −24.4 |
| 2025Q4 | 2025-12-31 | $6.66B | +9.0% | +5.0% | +4.0pp | 109.4 | −36.2 |
| 2025Q3 | 2025-09-30 | $6.44B | +3.2% | +3.7% | −0.5pp | 152.5 | +12.9 |
| 2025Q2 | 2025-06-30 | $6.6B | +2.0% | −1.9% | +3.9pp | 169.3 | +11.7 |
| 2025Q1 | 2025-03-31 | $6.2B | −4.8% | −1.6% | −3.3pp | 165.4 | −2.4 |
| 2024Q4 | 2024-12-31 | $6.11B | −3.9% | +6.8% | −10.7pp | 145.6 | −2.7 |
口径:剪刀差 = 存货同比 − 营收同比(pp,正值=存货增速快于营收);DIO = 存货/销货成本 × 91.25 天。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 2026-08-13 | 2026-08-13 | Guindo Chirfi | EVP, Access, Policy & Comms | S | 10,000 | $135.00 | $1.35M |
| 2026-08-12 | 2026-08-13 | Zachary Jennifer | EVP, General Counsel | S | 80,315 | $133.46 | $10.72M |
| 2026-08-12 | 2026-08-12 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | S | 600 | $132.04 | $79.22K |
| 2026-08-12 | 2026-08-12 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | S | 11,099 | $131.61 | $1.46M |
| 2026-08-11 | 2026-08-12 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | S | 5,427 | $132.35 | $718.26K |
| 2026-08-11 | 2026-08-12 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | S | 7,410 | $131.33 | $973.16K |
| 2026-08-10 | 2026-08-12 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | S | 20,784 | $130.43 | $2.71M |
| 2026-08-06 | 2026-08-10 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | S | 4,945 | $130.23 | $643.99K |
| 2026-08-06 | 2026-08-10 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | S | 300 | $131.02 | $39.31K |
| 2026-08-06 | 2026-08-10 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | S | 805 | $131.02 | $105.47K |
| 2026-08-06 | 2026-08-07 | Guindo Chirfi | EVP, Access, Policy & Comms | S | 15,000 | $131.00 | $1.97M |
| 2026-08-05 | 2026-08-07 | Maraldo David R. | EVP & Pres. MMD | S | 6,311 | $128.72 | $812.35K |
| 2026-08-05 | 2026-08-07 | Maraldo David R. | EVP & Pres. MMD | S | 2,686 | $128.72 | $345.74K |
| 2026-08-05 | 2026-08-07 | Maraldo David R. | EVP & Pres. MMD | S | 9,709 | $128.72 | $1.25M |
| 2026-08-05 | 2026-08-07 | Williams David Michael | EVP,Chief Info&Digital Officer | S | 13,542 | $128.77 | $1.74M |
| 2026-08-05 | 2026-08-07 | Williams David Michael | EVP,Chief Info&Digital Officer | S | 4,600 | $128.77 | $592.34K |
| 2026-08-05 | 2026-08-07 | Williams David Michael | EVP,Chief Info&Digital Officer | S | 34,705 | $128.77 | $4.47M |
| 2026-02-12 | 2026-02-12 | Guindo Chirfi | Chief Marketing Officer | S | 10,000 | $121.46 | $1.21M |
| 2026-02-10 | 2026-02-10 | Li Dean Y | Executive VP & President, MRL | S | 10,235 | $117.52 | $1.2M |
| 2026-02-09 | 2026-02-09 | Guindo Chirfi | Chief Marketing Officer | S | 10,000 | $118.41 | $1.18M |
| 2026-02-09 | 2026-02-09 | Zachary Jennifer | EVP, General Counsel | S | 25,946 | $119.15 | $3.09M |
| 2026-02-09 | 2026-02-09 | Zachary Jennifer | EVP, General Counsel | S | 56,792 | $119.15 | $6.77M |
| 2026-02-09 | 2026-02-09 | Zachary Jennifer | EVP, General Counsel | S | 38,835 | $119.15 | $4.63M |
| 2026-02-06 | 2026-02-06 | Williams David Michael | EVP,Chief Info&Digital Officer | S | 5,000 | $121.91 | $609.55K |
| 2026-02-06 | 2026-02-06 | Oosthuizen Johannes Jacobus | President, U.S. Market | S | 15,000 | $121.87 | $1.83M |
| 2026-02-06 | 2026-02-06 | DeLuca Richard R. | EVP&Pres, Merck Animal Heallth | S | 37,685 | $120.92 | $4.56M |
| 2026-02-05 | 2026-02-06 | Guindo Chirfi | Chief Marketing Officer | S | 20,000 | $121.88 | $2.44M |
| 2026-02-04 | 2026-02-06 | Smart Dalton E. III | SVP Fin. - Global Controller | S | 4,000 | $119.68 | $478.72K |
| 2026-02-04 | 2026-02-06 | Smart Dalton E. III | SVP Fin. - Global Controller | S | 2,400 | $119.68 | $287.23K |
| 2026-02-04 | 2026-02-06 | Litchfield Caroline | EVP & CFO | S | 41,997 | $119.61 | $5.02M |
| 2026-02-04 | 2026-02-06 | Li Dean Y | Executive VP & President, MRL | S | 15,087 | $118.77 | $1.79M |
| 2026-02-04 | 2026-02-06 | Davis Robert M | Chairman, CEO & President | S | 32,462 | $118.35 | $3.84M |
| 2026-02-04 | 2026-02-06 | Davis Robert M | Chairman, CEO & President | S | 14,972 | $117.38 | $1.76M |
| 2025-11-10 | 2025-11-12 | Downing Cristal N | Chief Comm. & Public Afrs Ofcr | S | 7,085 | $87.00 | $616.4K |
| 2025-11-03 | 2025-11-04 | Williams David Michael | EVP,Chief Info&Digital Officer | S | 8,614 | $83.59 | $720.04K |
| 2025-04-25 | 2025-04-29 | Smart Dalton E. III | SVP Fin. - Global Controller | S | 4,262 | $82.76 | $352.72K |
| 2025-02-19 | 2025-02-20 | Oosthuizen Johannes Jacobus | President, U.S. Market | S | 8,500 | $84.09 | $714.77K |
| 2025-02-13 | 2025-02-13 | Williams David Michael | EVP,Chief Info&Digital Officer | S | 6,000 | $85.34 | $512.04K |
| 2025-02-06 | 2025-02-07 | THULIN INGE G | — | P | 2,832.86 | $88.25 | $250K |
口径:Form 4/4A 公开市场买入(P)与卖出(S),申报人为董事或高管;汇总与集群为近 365 天,明细为最近 40 笔。 · 数据截至 2026-11-16 · 来源:SEC EDGAR Form 4
口径:SI 来自 FINRA(双周结算);SI% 分母 = SEC 封面总股本;借券费为 IBKR 报价(非全市场);卖空占比 = 当日卖空量/总成交量。 · 数据截至 SI 2026-10-30 · Reg SHO 2026-11-16 · 借券 2026-11-11 · 沿用上一版 · 来源:FINRA、IBKR、iBorrowDesk